These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8633828)
1. Prophylaxis of pneumocystis pneumonia and toxoplasmosis. Zamora L; Mallolas J; Gatell JM Ann Intern Med; 1996 Jun; 124(12):1096. PubMed ID: 8633828 [No Abstract] [Full Text] [Related]
2. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236 [No Abstract] [Full Text] [Related]
3. Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial. Murri R; Ammassari A; Pezzotti P; Cingolani A; De Luca A; Pallavicini F; Grillo R; Antinori A J Acquir Immune Defic Syndr; 2001 May; 27(1):49-55. PubMed ID: 11404520 [TBL] [Abstract][Full Text] [Related]
4. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598 [TBL] [Abstract][Full Text] [Related]
5. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS. Payen MC; De Wit S; Sommereijns B; Clumeck N Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502 [TBL] [Abstract][Full Text] [Related]
6. Response: Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients. Siscos SM; Neill BC; Tarantino IS; Aires DJ; Rajpara A J Am Acad Dermatol; 2021 Dec; 85(6):e371-e372. PubMed ID: 31015010 [No Abstract] [Full Text] [Related]
7. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488 [TBL] [Abstract][Full Text] [Related]
8. Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia. Coker RJ; Nieman R; McBride M; Mitchell DM; Harris JR; Weber JN Lancet; 1992 Oct; 340(8827):1099. PubMed ID: 1357487 [No Abstract] [Full Text] [Related]
9. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472 [TBL] [Abstract][Full Text] [Related]
10. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Opravil M; Joos B; Lüthy R Antimicrob Agents Chemother; 1994 May; 38(5):1197-9. PubMed ID: 8067765 [TBL] [Abstract][Full Text] [Related]
11. Dapsone, 2 birds with 1 stone: A response to "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients". Kneiber D; Kowalski EH; Amber KT J Am Acad Dermatol; 2021 Dec; 85(6):e369. PubMed ID: 31009669 [No Abstract] [Full Text] [Related]
12. [The impact of the prevention of cerebral toxoplasmosis]. Katlama C J Neuroradiol; 1995 Sep; 22(3):193-5. PubMed ID: 7472536 [TBL] [Abstract][Full Text] [Related]
13. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis. Antinori A; Murri R; Ammassari A AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743 [No Abstract] [Full Text] [Related]
14. Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia. Mallolas J; Zamora L; Gatell JM; Miró JM; Soriano E Lancet; 1991 May; 337(8750):1162-3. PubMed ID: 1674036 [No Abstract] [Full Text] [Related]
16. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection. Dorrell L; McCallum AK; Snow MH; Ong EL AIDS Patient Care; 1995 Oct; 9(5):224-8. PubMed ID: 11361401 [No Abstract] [Full Text] [Related]
18. Prevention of infection due to Pneumocystis carinii. Fishman JA Antimicrob Agents Chemother; 1998 May; 42(5):995-1004. PubMed ID: 9593116 [No Abstract] [Full Text] [Related]
19. A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. van Oosterhout JJ; Laufer MK; Graham SM; Thumba F; Perez MA; Chimbiya N; Wilson L; Chagomerana M; Molyneux ME; Zijlstra EE; Taylor TE; Plowe CV J Acquir Immune Defic Syndr; 2005 Aug; 39(5):626-31. PubMed ID: 16044018 [TBL] [Abstract][Full Text] [Related]
20. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC; Rimland D Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]